Search Results Search Sort by RelevanceMost Recent Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612. Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612.
Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612.